Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
1f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.705
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.712
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.925
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.383
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.631
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.822
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.301
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.871
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.907
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Creatinine
|
HET
|
4f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Creatinine
|
HOM
|
6f:4m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.469
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.755
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
3f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.153
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.448
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.661
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.522
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.663
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.721
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0224
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.593
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.596
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
6f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00984
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.236
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.460
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.283
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.600
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.174
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.310
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.605
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.666
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.694
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.873
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0496
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0588
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.342
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.382
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.619
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0887
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.308
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.654
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.721
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.889
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.746
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0398
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.503
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.522
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.366
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.592
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.953
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.238
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.345
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.380
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
2f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.502
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.226
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HET
|
6f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.521
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.183
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.832
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:50m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.219
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.650
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.214
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HET
|
4f:2m
|
Linear Mixed Model framework, LME, not including Weight
|
0.801
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.901
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.137
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.505
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.969
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
f:2m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
8f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.720
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.887
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
4f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
1f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.00575
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
6f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.158
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.852
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
f:1m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
4f:3m
|
|
|
NotProcessed |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
6f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000451
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
1f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.258
|
Successful |
Cbln3tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
4f:2m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.418
|
Successful |